(Q37314324)

19 August 2017

4 references

9 October 2019

7 November 2019

18 September 2020

18 November 2020

Renal effects of levosimendan: a consensus report (English)

1 reference

19 August 2017

1 reference

9 October 2019

1 reference

7 November 2019

1 reference

18 September 2020

1 reference

18 November 2020

1 reference

19 August 2017

Elena Grossini

0 references

Anders Oldner

0 references

Piero Pollesello

0 references

Andrea Morelli

0 references

Mehmet B Yilmaz

0 references

Veli-Pekka Harjola

1 reference

19 August 2017

Alexandre Mebazaa

1 reference

19 August 2017

John T Parissis

1 reference

19 August 2017

Gerhard Wikström

1 reference

19 August 2017

José C Silva Cardoso

1 reference

19 August 2017

István Édes

1 reference

19 August 2017

Francesco Fedele

1 reference

19 August 2017

Matti Kivikko

1 reference

19 August 2017

Julia Hasslacher

1 reference

19 August 2017

Jos le Noble

1 reference

19 August 2017

Ignacio Oulego Erroz

1 reference

19 August 2017

Alexander Parkhomenko

1 reference

19 August 2017

Gerhard Poelzl

1 reference

19 August 2017

Sebastian Rehberg

1 reference

19 August 2017

Sven-Erik Ricksten

1 reference

19 August 2017

Luís M Rodríguez Fernández

1 reference

19 August 2017

Markku Salmenperä

1 reference

19 August 2017

Sascha Treskatsch

1 reference

19 August 2017

Bojan Vrtovec

1 reference

19 August 2017

1 December 2013

5 references

Cardiovascular Drugs and Therapy

19 August 2017

9 October 2019

7 November 2019

18 September 2020

18 November 2020

5 references

19 August 2017

9 October 2019

7 November 2019

18 September 2020

18 November 2020

1 reference

19 August 2017

1 reference

19 August 2017

581-590

1 reference

Creative Commons Attribution-NonCommercial 2.0 Generic

19 August 2017

start time

9 August 2013

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

The role of the kidney in heart failure

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Effects of calcium sensitizer OR-1986 on a cardiovascular mortality and myocardial remodelling in hypertensive Dahl/Rapp rats

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Effects of levosimendan on the energy balance: preclinical and clinical evidence

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Intracellular ATP can regulate afferent arteriolar tone via ATP-sensitive K+ channels in the rabbit

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Levosimendan modulates programmed forms of cell death through K(ATP) channels and nitric oxide.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Effectiveness and safety of levosimendan in clinical practice.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

A mechanism by which atrial natriuretic factor mediates its glomerular actions.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Effect of short-term treatment with levosimendan on oxidative stress in renal tissues of rats.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Effect of levosimendan in patients with severe systolic heart failure and worsening renal function.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Levosimendan protection against kidney ischemia/reperfusion injuries in anesthetized pigs.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Effects of levosimendan on renal function in patients undergoing coronary artery surgery

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Levosimendan preserves the contractile responsiveness of hypoxic human myocardium via mitochondrial K(ATP) channel and potential pERK 1/2 activation.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Reducing the risk of major elective non-cardiac surgery: is there a role for levosimendan in the preoperative optimization of cardiac function?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Dopamine increases renal oxygenation: a clinical study in post-cardiac surgery patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Safety and effectiveness of levosimendan in patients with predominant right heart failure

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Acute renal failure in patients with severe sepsis and septic shock--a significant independent risk factor for mortality: results from the German Prevalence Study

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

The influence of levosimendan and iloprost on renal ischemia-reperfusion: an experimental study

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Levosimendan protects against experimental endotoxemic acute renal failure

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Hemodynamic effects of levosimendan following cardiac surgery

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Cardiac and renal effects of levosimendan, arginine vasopressin, and norepinephrine in lipopolysaccharide-treated rabbits

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Levosimendan in off-pump coronary artery bypass: a four-times masked controlled study

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Sustained hemodynamic effects of intravenous levosimendan

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Effects of trimetazidine on tissue damage in kidney after hindlimb ischemia-reperfusion

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3830192

No beneficial effects of levosimendan in acute porcine endotoxaemia

2 September 2018

1 reference

12 December 2020

Management of acute cardiac failure by intracoronary administration of levosimendan

1 reference

12 December 2020

[Acute renal failure after cardiac surgery: evaluation of the RIFLE criteria]

1 reference

12 December 2020

Peri-operative interventions, but not inflammatory mediators, increase risk of acute kidney injury after cardiac surgery: a prospective cohort study

1 reference

12 December 2020

Effects of levosimendan on right ventricular function in patients with advanced heart failure

1 reference

12 December 2020

Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation

1 reference

12 December 2020

10.1007/S10557-013-6485-6

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

23929366

1 reference